{"id":"https://openalex.org/W7225610609","doi":"https://doi.org/10.58600/eurjther3242","title":"Effects of Allantoin Combined with Bevacizumab on Estrogen Receptor-Positive and Triple-Negative Breast Cancer Cells","display_name":"Effects of Allantoin Combined with Bevacizumab on Estrogen Receptor-Positive and Triple-Negative Breast Cancer Cells","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225610609","doi":"https://doi.org/10.58600/eurjther3242"},"language":"en","primary_location":{"id":"doi:10.58600/eurjther3242","doi":"https://doi.org/10.58600/eurjther3242","is_oa":true,"landing_page_url":"https://doi.org/10.58600/eurjther3242","pdf_url":"https://www.eurjther.com/index.php/home/article/download/3242/2014","source":{"id":"https://openalex.org/S4210237376","display_name":"European Journal of Therapeutics","issn_l":"2564-7040","issn":["2564-7040","2564-7784"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["erih-plus","poland-20","russia-white-list-3","tr-dizin"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.eurjther.com/index.php/home/article/download/3242/2014","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074590549","display_name":"G\u00fcl\u00e7in Ekizceli","orcid":"https://orcid.org/0000-0001-9513-5706","observed_orcids":["https://orcid.org/0000-0001-9513-5706"]},"institutions":[{"id":"https://openalex.org/I40790370","display_name":"Yalova University","ror":"https://ror.org/01x18ax09","country_code":"TR","type":"education","lineage":["https://openalex.org/I40790370"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Gulcin Ekizceli","raw_affiliation_strings":["Department of Histology and Embryology, Faculty of Medicine, Yalova University, Yalova, T\u00fcrkiye"],"raw_orcid":"https://orcid.org/0000-0001-9513-5706","affiliations":[{"raw_affiliation_string":"Department of Histology and Embryology, Faculty of Medicine, Yalova University, Yalova, T\u00fcrkiye","institution_ids":["https://openalex.org/I40790370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065010864","display_name":"Tu\u011f\u00e7e Alada\u011f","orcid":"https://orcid.org/0000-0003-3250-6113","observed_orcids":["https://orcid.org/0000-0003-3250-6113"]},"institutions":[{"id":"https://openalex.org/I4387154071","display_name":"Afyonkarahisar Sa\u011fl\u0131k Bilimleri \u00dcniversitesi","ror":"https://ror.org/00sfg6g55","country_code":"TR","type":"education","lineage":["https://openalex.org/I4387154071"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Tugce Aladag","raw_affiliation_strings":["Department of Histology and Embryology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, T\u00fcrkiye"],"raw_orcid":"https://orcid.org/0000-0003-3250-6113","affiliations":[{"raw_affiliation_string":"Department of Histology and Embryology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, T\u00fcrkiye","institution_ids":["https://openalex.org/I4387154071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015997462","display_name":"Ya\u011fmur Dilber","orcid":"https://orcid.org/0000-0002-7451-2389","observed_orcids":["https://orcid.org/0000-0002-7451-2389"]},"institutions":[{"id":"https://openalex.org/I197907453","display_name":"Akdeniz University","ror":"https://ror.org/01m59r132","country_code":"TR","type":"education","lineage":["https://openalex.org/I197907453"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Yagmur Dilber","raw_affiliation_strings":["Department of Medical Biochemistry, Faculty of Medicine, Akdeniz University, Antalya, T\u00fcrkiye"],"raw_orcid":"https://orcid.org/0000-0002-7451-2389","affiliations":[{"raw_affiliation_string":"Department of Medical Biochemistry, Faculty of Medicine, Akdeniz University, Antalya, T\u00fcrkiye","institution_ids":["https://openalex.org/I197907453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045314549","display_name":"Fatma F\u0131rat","orcid":"https://orcid.org/0000-0003-0027-5138","observed_orcids":["https://orcid.org/0000-0003-0027-5138"]},"institutions":[{"id":"https://openalex.org/I4387154071","display_name":"Afyonkarahisar Sa\u011fl\u0131k Bilimleri \u00dcniversitesi","ror":"https://ror.org/00sfg6g55","country_code":"TR","type":"education","lineage":["https://openalex.org/I4387154071"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Fatma Firat","raw_affiliation_strings":["Department of Histology and Embryology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, T\u00fcrkiye"],"raw_orcid":"https://orcid.org/0000-0003-0027-5138","affiliations":[{"raw_affiliation_string":"Department of Histology and Embryology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, T\u00fcrkiye","institution_ids":["https://openalex.org/I4387154071"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.9620000123977661},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.7929999828338623},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9079999923706055},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.9210000038146973},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.6790000200271606},{"id":"https://openalex.org/keywords/wound-healing","display_name":"wound healing","score":0.531000018119812},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.8889999985694885},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8199999928474426},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.878000020980835},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":1.0},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.6669999957084656},{"id":"https://openalex.org/keywords/wound-closure","display_name":"wound closure","score":0.367000013589859},{"id":"https://openalex.org/keywords/cell-migration","display_name":"cell migration","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8034999966621399},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.6089000105857849},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.5730999708175659},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5178999900817871},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.461899995803833},{"id":"https://openalex.org/C2776073210","wikidata":"https://www.wikidata.org/wiki/Q409804","display_name":"Allantoin","level":2,"score":0.45080000162124634},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4325000047683716},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.37959998846054077},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.37220001220703125},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.3718999922275543},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3662000000476837},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35929998755455017},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35359999537467957},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3434000015258789},{"id":"https://openalex.org/C2780269544","wikidata":"https://www.wikidata.org/wiki/Q1509074","display_name":"Wound healing","level":2,"score":0.3402000069618225},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.3253999948501587},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.3147999942302704},{"id":"https://openalex.org/C146285616","wikidata":"https://www.wikidata.org/wiki/Q7916455","display_name":"Vascular endothelial growth factor A","level":4,"score":0.3116999864578247},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3095000088214874},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30809998512268066},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.29429998993873596},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.29339998960494995},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.2921000123023987},{"id":"https://openalex.org/C123012128","wikidata":"https://www.wikidata.org/wiki/Q5376430","display_name":"Endothelial stem cell","level":3,"score":0.2840999960899353},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.28279998898506165},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.27140000462532043},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.2612999975681305}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.58600/eurjther3242","doi":"https://doi.org/10.58600/eurjther3242","is_oa":true,"landing_page_url":"https://doi.org/10.58600/eurjther3242","pdf_url":"https://www.eurjther.com/index.php/home/article/download/3242/2014","source":{"id":"https://openalex.org/S4210237376","display_name":"European Journal of Therapeutics","issn_l":"2564-7040","issn":["2564-7040","2564-7784"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["erih-plus","poland-20","russia-white-list-3","tr-dizin"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Therapeutics","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.58600/eurjther3242","doi":"https://doi.org/10.58600/eurjther3242","is_oa":true,"landing_page_url":"https://doi.org/10.58600/eurjther3242","pdf_url":"https://www.eurjther.com/index.php/home/article/download/3242/2014","source":{"id":"https://openalex.org/S4210237376","display_name":"European Journal of Therapeutics","issn_l":"2564-7040","issn":["2564-7040","2564-7784"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["erih-plus","poland-20","russia-white-list-3","tr-dizin"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225610609.pdf","grobid_xml":"https://content.openalex.org/works/W7225610609.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W2025284198","https://openalex.org/W2026523347","https://openalex.org/W2045563337","https://openalex.org/W2077129920","https://openalex.org/W2113231588","https://openalex.org/W2119341575","https://openalex.org/W2124748060","https://openalex.org/W2126275851","https://openalex.org/W2134967712","https://openalex.org/W2158602154","https://openalex.org/W2168182874","https://openalex.org/W2170453842","https://openalex.org/W2221898953","https://openalex.org/W2482246608","https://openalex.org/W2502571399","https://openalex.org/W2557100819","https://openalex.org/W2914867846","https://openalex.org/W2938150871","https://openalex.org/W2969032330","https://openalex.org/W2973077889","https://openalex.org/W3081285438","https://openalex.org/W3111963281","https://openalex.org/W3128646645","https://openalex.org/W4220866473","https://openalex.org/W4294189863","https://openalex.org/W4386084830","https://openalex.org/W4387424442","https://openalex.org/W4390144680","https://openalex.org/W4403358838","https://openalex.org/W4409251975","https://openalex.org/W4409588723","https://openalex.org/W4411036462","https://openalex.org/W4411673676","https://openalex.org/W7160759424"],"related_works":["https://openalex.org/W4402561192","https://openalex.org/W2320674718","https://openalex.org/W4402561310","https://openalex.org/W3174990508","https://openalex.org/W2277206491","https://openalex.org/W1958231732","https://openalex.org/W2158885282","https://openalex.org/W4417105203","https://openalex.org/W2143556151","https://openalex.org/W2752875184"],"abstract_inverted_index":{"Objective:":[0],"This":[1],"study":[2],"aimed":[3],"to":[4,14,72,90,286,365],"evaluate":[5],"the":[6,12,67,95,128,194,203,218,226,273,288,329,345,363],"modulatory":[7],"effect":[8],"of":[9,97,174,225,234,243,321,347],"Allantoin":[10,126,142,209,271,297,348,361],"on":[11,30],"response":[13,364],"Bevacizumab":[15,129,144,219,274,299,350,366],"in":[16,40,94,135,146,152,155,178,182,190,213,257,304,314,370],"estrogen":[17],"receptor-positive":[18],"(MCF-7)":[19],"and":[20,36,45,54,59,111,127,143,149,220,237,260,272,298,316,349,369],"triple-negative":[21],"(MDA-MB-231)":[22],"breast":[23,293],"cancer":[24,294],"cell":[25,47,153,157,215,230,326,352],"lines,":[26,216,327],"with":[27,51,141,164,229,254,296,356],"a":[28,82,117,147,248,267,334],"focus":[29],"proliferation,":[31],"angiogenesis-related":[32],"markers,":[33],"inflammatory":[34,331],"responses,":[35],"wound":[37,211,227],"closure":[38,78,212],"under":[39],"vitro":[41],"conditions.":[42],"Methods:":[43],"MCF-7":[44,179],"MDA-MB-231":[46,183],"lines":[48],"were":[49,88,132],"treated":[50],"Allantoin,":[52],"Bevacizumab,":[53],"their":[55],"combination":[56,160,195,221,346],"for":[57],"24":[58],"48":[60,207],"hours.":[61,208],"Cell":[62],"viability":[63,154,239],"was":[64,79,162],"assessed":[65],"using":[66,81,116,134],"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium":[68],"bromide":[69],"(MTT)":[70],"assay":[71],"determine":[73],"effective":[74],"dose":[75],"ranges.":[76],"Wound":[77],"evaluated":[80],"wound-healing":[83],"(scratch)":[84],"assay.":[85],"Immunocytochemical":[86],"analyses":[87],"performed":[89],"assess":[91],"relative":[92],"changes":[93,255,354],"immunoreactivity":[96,186,201],"Ki-67,":[98],"vascular":[99],"endothelial":[100],"growth":[101],"factor":[102,105],"(VEGF),":[103],"nuclear":[104],"kappa":[106],"B":[107],"(NF-\u03baB),":[108],"interleukin-6":[109],"(IL-6),":[110],"tumor":[112],"necrosis":[113],"factor-alpha":[114],"(TNF-\u03b1)":[115],"semi-quantitative":[118],"H-score":[119],"method.":[120],"In":[121],"addition,":[122],"potential":[123],"interactions":[124],"between":[125,270],"Fab":[130,275],"fragment":[131,276],"analyzed":[133],"silico":[136],"molecular":[137],"docking.":[138],"Results:":[139],"Treatment":[140],"resulted":[145],"time-":[148],"dose-dependent":[150],"decrease":[151],"both":[156,214],"lines.":[158],"The":[159,172,319],"treatment":[161,252],"associated":[163],"decreased":[165],"Ki-67":[166],"immunoreactivity,":[167],"indicating":[168],"reduced":[169,238],"proliferative":[170],"activity.":[171],"levels":[173],"VEGF":[175,185,200],"protein":[176],"dropped":[177],"cells,":[180],"whereas":[181,217],"cells":[184,295],"increased":[187,210],"over":[188],"time":[189],"all":[191],"groups":[192,222],"except":[193],"group,":[196],"which":[197],"showed":[198,223],"lower":[199],"than":[202,241],"time-matched":[204],"control":[205],"at":[206],"widening":[224],"area":[228],"detachment,":[231],"reflecting":[232],"loss":[233],"monolayer":[235],"integrity":[236],"rather":[240],"inhibition":[242],"migration.":[244],"Inflammatory":[245],"markers":[246],"exhibited":[247],"variable":[249],"pattern":[250],"across":[251,325],"groups,":[253],"observed":[256,289],"NF-\u03baB,":[258],"TNF-\u03b1,":[259],"IL-6":[261],"immunoreactivity.":[262],"Docking":[263],"analysis":[264],"predicted":[265],"only":[266],"weak":[268],"interaction":[269],"(\u22125.4":[277],"kcal/mol),":[278],"suggesting":[279],"that":[280,344],"direct":[281],"drug-drug":[282],"binding":[283],"is":[284],"unlikely":[285],"explain":[287],"effects.":[290],"Conclusion:":[291],"Co-treating":[292],"induced":[300],"distinct":[301],"behavioral":[302],"shifts":[303],"vitro;":[305],"nevertheless,":[306],"these":[307,322,340],"preliminary":[308],"observations":[309],"necessitate":[310],"subsequent":[311],"validation":[312],"through":[313],"vivo":[315,371],"translational":[317],"models.":[318],"magnitude":[320],"effects":[323],"differed":[324],"while":[328],"fluctuating":[330],"patterns":[332],"highlight":[333],"multifaceted":[335],"regulatory":[336],"response.":[337],"Taken":[338],"together,":[339],"exploratory":[341],"findings":[342],"show":[343],"produced":[351],"line-dependent":[353],"compared":[355],"either":[357],"agent":[358],"alone;":[359],"whether":[360],"modulates":[362],"requires":[367],"mechanistic":[368],"confirmation.":[372]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}